MAP2K1 and precursor B-cell acute lymphoblastic leukemia: Low levels of MIR335 are associated with poor outcome in primary pediatric B-ALL, and forced expression of this micro RNA decreased MEK1 expression and increased cellular sensitivity to prednisolone [56].